Silence Therapeutics's market cap is currently $233.30M. The company's EPS TTM is $-1.671; its P/E ratio is ―; Silence Therapeutics is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	£ 25.38M	£ 17.50M	£ 12.41M	£ 5.48M	£ 244.00K
Gross Profit	£ 15.06M	£ 6.62M	£ 4.96M	£ 1.72M	£ 244.00K
Operating Income	£ -49.60M	£ -48.59M	£ -45.81M	£ -35.85M	£ -22.73M
EBITDA	£ -49.78M	£ -47.88M	£ -45.42M	£ -35.53M	£ -22.36M
Net Income	£ -43.27M	£ -40.49M	£ -39.41M	£ -32.55M	£ -19.58M
Balance Sheet
Cash & Short-Term Investments	£ 54.03M	£ 71.14M	£ 73.54M	£ 37.45M	£ 33.52M
Total Assets	£ 93.82M	£ 107.50M	£ 96.19M	£ 85.97M	£ 46.08M
Total Debt	£ 272.00K	£ 446.00K	£ 137.00K	£ 341.00K	£ 287.00K
Net Debt	£ -53.76M	£ -54.37M	£ -73.40M	£ -27.11M	£ -13.23M
Total Liabilities	£ 76.77M	£ 85.43M	£ 87.67M	£ 76.91M	£ 25.17M
Stockholders' Equity	£ 17.05M	£ 22.07M	£ 8.53M	£ 9.06M	£ 20.91M
Cash Flow
Free Cash Flow	£ -39.40M	£ -45.90M	£ 5.47M	£ -11.29M	£ 1.72M
Operating Cash Flow	£ -39.35M	£ -45.46M	£ 6.81M	£ -10.78M	£ 1.73M
Investing Cash Flow	£ 16.43M	£ -16.54M	£ 8.68M	£ 9.62M	£ -15.02M
Financing Cash Flow	£ 25.16M	£ 43.05M	£ 30.71M	£ 15.43M	£ 5.27M

Currency in GBP

Silence Therapeutics Earnings and Revenue History

Income Statement >

Silence Therapeutics Debt to Assets

Balance Sheet >

Silence Therapeutics Cash Flow

Cash Flow >

Silence Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing